Chao He
President at SHANGHAI MICROPORT MEDBOT (GROUP) CO., LTD.
Net worth: 1 078 M $ as of 2024-03-30
Profile
Chao He occupies the position of President & Executive Director at Shanghai MicroPort MedBot (Group) Co., Ltd. He received a graduate degree from Hefei University of Technology.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2023-06-29 | 627,852,473 ( 65.95% ) | 1 078 M $ | 2024-03-30 |
Chao He active positions
Companies | Position | Start |
---|---|---|
SHANGHAI MICROPORT MEDBOT (GROUP) CO., LTD. | President | 2021-06-08 |
Former positions of Chao He
Companies | Position | End |
---|---|---|
Shanghai Microport Medical (Group) Co., Ltd.
Shanghai Microport Medical (Group) Co., Ltd. Electronic Equipment/InstrumentsElectronic Technology Shanghai Microport Medical (Group) Co. Ltd. develops, manufactures, and markets medical products for interventional cardiology and peripheral vascular diseases. The company’s products include cardiovascular, endovascular, neurovascular, peripheral vascular, coronary stent systems, balloon catheters, peripheral and cardiac retractors. The company’s products are used in cardiac catheter laboratories. The company was founded in 1998 and is based in Shanghai, China. | Director/Board Member | 2015-04-30 |
Training of Chao He
Hefei University of Technology | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
SHANGHAI MICROPORT MEDBOT (GROUP) CO., LTD. | Health Technology |
Private companies | 1 |
---|---|
Shanghai Microport Medical (Group) Co., Ltd.
Shanghai Microport Medical (Group) Co., Ltd. Electronic Equipment/InstrumentsElectronic Technology Shanghai Microport Medical (Group) Co. Ltd. develops, manufactures, and markets medical products for interventional cardiology and peripheral vascular diseases. The company’s products include cardiovascular, endovascular, neurovascular, peripheral vascular, coronary stent systems, balloon catheters, peripheral and cardiac retractors. The company’s products are used in cardiac catheter laboratories. The company was founded in 1998 and is based in Shanghai, China. | Electronic Technology |
- Stock Market
- Insiders
- Chao He